Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Elisa Gremese and Stefano Alivernini.
Elisa Gremese
Connection Strength
2.937
Stefano Alivernini
  1. No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic. Rheumatology (Oxford). 2020 09 01; 59(9):2644-2646.
    View in: PubMed
    Score: 0.901
  2. Comparative analysis of synovial inflammation after SARS-CoV-2 infection. Ann Rheum Dis. 2020 Jul 06.
    View in: PubMed
    Score: 0.891
  3. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021 06 18; 6(13).
    View in: PubMed
    Score: 0.238
  4. RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021 05 18; 118(20).
    View in: PubMed
    Score: 0.236
  5. Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
    View in: PubMed
    Score: 0.226
  6. Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases. Eur J Clin Invest. 2020 Sep; 50(9):e13342.
    View in: PubMed
    Score: 0.224
  7. Telemedicine will not keep us apart in COVID-19 pandemic. Ann Rheum Dis. 2020 Jun 05.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.